日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer

外周血T细胞的免疫学特征揭示了p53MVA疫苗和帕博利珠单抗治疗晚期卵巢癌患者的疗效

Kos, Ferdynand J; Frankel, Paul; Cristea, Mihaela; Eng, Melissa; Tinsley, Raechelle; Dempsey, Shannon; Ruel, Nora; Stewart, Daphne; Dellinger, Thanh H; Diamond, Don J

Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab

一名接受 p53MVA 疫苗联合帕博利珠单抗治疗的三阴性乳腺癌患者,其皮肤转移灶完全消退并伴有全身免疫反应。

Yuan, Yuan; Kos, Ferdynand J; He, Ting-Fang; Yin, Hongwei H; Li, Mengsha; Hardwick, Nicola; Zurcher, Kathryn; Schmolze, Daniel; Lee, Peter; Pillai, Raju K; Chung, Vincent; Diamond, Don J

Sustained CD4(+) T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide

接受放疗和替莫唑胺治疗的高级别胶质瘤患者中,持续存在由 CD4(+) T 细胞驱动的淋巴细胞减少症,且无代偿性 IL-7/IL-15 反应。

Ellsworth, Susannah; Balmanoukian, Ani; Kos, Ferdynand; Nirschl, Christopher J; Nirschl, Thomas R; Grossman, Stuart A; Luznik, Leo; Drake, Charles G

Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity

基于结构的改变MHC II类限制性肽配体的设计及其异质免疫原性

Chen, Shuming; Li, Yili; Depontieu, Florence R; McMiller, Tracee L; English, A Michelle; Shabanowitz, Jeffrey; Kos, Ferdynand; Sidney, John; Sette, Alessandro; Rosenberg, Steven A; Hunt, Donald F; Mariuzza, Roy A; Topalian, Suzanne L

Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.

人类乳头瘤病毒 16 型相关的宫颈上皮内瘤变将 CD8 T 细胞排除在发育不良的上皮之外

Trimble Cornelia L, Clark Rachael A, Thoburn Christopher, Hanson Nicole C, Tassello Jodie, Frosina Denise, Kos Ferdynand, Teague Jessica, Jiang Ying, Barat Nicole C, Jungbluth Achim A

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3

一项针对HPV16+宫颈上皮内瘤变2/3的人乳头瘤病毒DNA疫苗I期临床试验

Trimble, Cornelia L; Peng, Shiwen; Kos, Ferdynand; Gravitt, Patti; Viscidi, Raphael; Sugar, Elizabeth; Pardoll, Drew; Wu, T C

HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.

针对痘苗病毒的 HLA I 类限制性反应可识别多种蛋白质,这些蛋白质主要与毒力和病毒基因调控有关

Oseroff Carla, Kos Ferdynand, Bui Huynh-Hoa, Peters Bjoern, Pasquetto Valerie, Glenn Jean, Palmore Tara, Sidney John, Tscharke David C, Bennink Jack R, Southwood Scott, Grey Howard M, Yewdell Jonathan W, Sette Alessandro